G Medical Innovations IPO Presentation Deck

Offering Summary Issuer Symbol Expected Offering Size Securities Offered Use of Proceeds Sole Book-Runner G Medical Innovations Holdings Ltd. Nasdaq: GMVD $18,000,000 Ordinary shares (Or for purchasers whose purchase of Ordinary Shares in this offering would otherwise result in the purchaser beneficially owning more than 4.99% of the outstanding ordinary shares, pre-funded warrants in lieu thereof) General corporate purposes, which include: Financing operations • Capital expenditures • Business development Repayment in full of the April 2021 Financing Debentures Potential M&A ThinkEquity 3

View entire presentation